Ticker Details
United Therapeutics Corporation United Therapeutics Corp is engaged in the healthcare sector. Its core offering includes pharmaceutical products to address unmet medical needs of patients.
IPO Date:	June 17, 1999
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$25.19B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.74 | 1.39%
Avg Daily Range (30 D):	$8.24 | 1.53%
Avg Daily Range (90 D):	$6.50 | 1.28%

Institutional Daily Volume
Avg Daily Volume:	.52M
Avg Daily Volume (30 D):	.56M
Avg Daily Volume (90 D):	.37M

Trade Size
Avg Trade Size (Sh.):	84
Avg Trade Size (Sh.) (30 D):	24
Avg Trade Size (Sh.) (90 D):	21

Institutional Trades
Total Institutional Trades:	14,472
Avg Institutional Trade:	$5.34M
Avg Institutional Trade (30 D):	$41.44M
Avg Institutional Trade (90 D):	$35.95M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$10.3M
Avg Closing Trade (30 D):	$50.51M
Avg Closing Trade (90 D):	$41.68M
Avg Closing Volume:	59.32K

News

Apr 8, 2026 @ 5:00 PM Interstitial Lung Disease Market to Witness Accele... Source: Delveinsight

Mar 30, 2026 @ 4:40 PM Stocks Rise As Powell's Remarks Cool Rate Fears: W... Source: Piero Cingari

Mar 30, 2026 @ 2:08 PM Why Is United Therapeutics Stock Soaring Monday? Source: Vandana Singh

Mar 2, 2026 @ 3:32 PM United Therapeutics' Trial Shows 55% Drop in Lung ... Source: Vandana Singh

Jan 26, 2026 @ 1:55 PM United Therapeutics Reports Early Success For Exte... Source: Vandana Singh

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$30.13		$30.13
Diluted EPS	$27.86		$27.86
Revenue	$3.18B		$3.18B
Gross Profit	$2.8B		$2.8B
Net Income / Loss	$1.33B		$1.33B
Operating Income / Loss	$1.49B		$1.49B
Cost of Revenue	$384.4M		$384.4M
Net Cash Flow	$-140.1M		$-140.1M
PE Ratio	20.52

Splits
Sep 23, 2009	2:1